Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neos Therapeutics Cmn (NEOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 184,680
  • Shares Outstanding, K 27,360
  • Annual Sales, $ 9,150 K
  • Annual Income, $ -83,330 K
  • 36-Month Beta -0.79
  • Price/Sales 20.47
  • Price/Cash Flow 0.00
  • Price/Book 12.26

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.40 +1.56%
on 07/26/17
7.65 -15.03%
on 07/03/17
-0.55 (-7.80%)
since 06/27/17
3-Month
6.40 +1.56%
on 07/26/17
9.60 -32.29%
on 06/19/17
-0.95 (-12.75%)
since 04/27/17
52-Week
4.85 +34.02%
on 02/03/17
9.60 -32.29%
on 06/19/17
-2.61 (-28.65%)
since 07/27/16

Most Recent Stories

More News
Shares of Depomed Inc Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (DEPO, NEOS, HZNP, TTPH, LCI)

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

LCI : 20.60 (-1.20%)
HZNP : 12.66 (-4.24%)
DEPO : 10.44 (-4.31%)
NEOS : 6.50 (-3.70%)
TTPH : 6.96 (-11.68%)
Neos Therapeutics Announces Pricing of Underwritten Public Offering of $32.4 Million of Common Stock

Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release...

NEOS : 6.50 (-3.70%)
Neos Therapeutics Announces Proposed Offering of Common Stock

Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release...

NEOS : 6.50 (-3.70%)
The Zacks Analyst Blog Highlights: Novartis, Roche, Shire, Neos and Novo Nordisk

The Zacks Analyst Blog Highlights: Novartis, Roche, Shire, Neos and Novo Nordisk

NVO : 41.49 (-1.19%)
NVS : 84.97 (+0.14%)
SHPG : 169.36 (-0.26%)
RHHBY : 31.6100 (-0.16%)
NEOS : 6.50 (-3.70%)
Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod

All major pharma stocks were up this week with companies like Novartis (NVS) presenting positive data and others gaining FDA approval.

NVO : 41.49 (-1.19%)
MRK : 63.69 (+3.06%)
NVS : 84.97 (+0.14%)
SHPG : 169.36 (-0.26%)
RHHBY : 31.6100 (-0.16%)
BMY : 54.24 (-3.11%)
NEOS : 6.50 (-3.70%)
Neos Therapeutics to Present at the JMP Securities 2017 Life Sciences Conference

Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release...

NEOS : 6.50 (-3.70%)
Key FDA Events to Watch Out for in Jun 2017

Companies like Portola (PTLA) are awaiting key FDA decisions this month which could send their stocks soaring in case of a positive response.

LGND : 121.65 (-1.53%)
NVO : 41.49 (-1.19%)
SHPG : 169.36 (-0.26%)
RHHBY : 31.6100 (-0.16%)
PTLA : 63.54 (-3.14%)
ALKS : 54.90 (-4.64%)
NEOS : 6.50 (-3.70%)
Neos Therapeutics to Present at Jefferies 2017 Global Healthcare Conference

Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release...

NEOS : 6.50 (-3.70%)
Neos Therapeutics to Present at 2017 UBS Global Healthcare Conference

Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release...

NEOS : 6.50 (-3.70%)
Neos Therapeutics to Host First Quarter 2017 Financial Results Conference Call on May 9, 2017

Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release...

NEOS : 6.50 (-3.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

See More

Business Summary

Neos Therapeutics, Inc. is engaged in developing, manufacturing and commercializing products for the treatment of attention deficit hyperactivity disorder using drug delivery technologies. Its product candidates include NT-0102 methylphenidate XR orally disintegrating tablet for the treatment of ADHD;...

See More

Support & Resistance

2nd Resistance Point 7.12
1st Resistance Point 6.93
Last Price 6.50
1st Support Level 6.48
2nd Support Level 6.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.